{
 "as_of": "2026-11-06",
 "cmr": "ca-cm-kg/TSX/SVA",
 "fence": "The page is the record's research on the issuer — no analyst, no rating, no view.",
 "markdown": "The page is the record's research on the issuer — no analyst, no rating, no view.\n\n# Sernova Biotherapeutics Inc. (TSX: SVA) — research page\n\nAs of 2026-11-06 · ca-cm-kg · record version 1\n\n## Identity and listing\n\nThe issuer is Sernova Biotherapeutics Inc., listed on the TSX under ticker SVA. The ISIN is CA81752F1062 and the LEI is not on the record (ISIN not in the GLEIF ISIN-to-LEI mapping file). The security type is Corporate, the segment is not on the record, the sector is Life Sciences, and the jurisdiction is not on the record (none found). The listing status is listed, not halted.\n\n## The disclosure read\n\nThe record holds 13 filings in the twelve months to 2026-11-06, across 11 filing days. The median gap between filing days is 14.0 days. The latest filing is dated 2026-10-19, is a newswire release, and is 18 days before the record date. On the TSX the median cadence gap is 16 days, the median filings count is 0.0, and the median latency is 3.0 days across 2,270 issuers. In the Life Sciences sector the median cadence gap is 17.5 days, the median filings count is 7.0, and the median latency is 14 days across 200 issuers.\n\n## Auditor\n\nThe auditor of record is Ernst & Young LLP, and its location is not on the record. The record holds no auditor changes.\n\n## Events and halts\n\nThe record holds no listing, delisting, name change, domicile change or segment move events. The halt flag reads listed, not halted.\n\n## Orderability\n\nUnder the rule version acm-68000/ca/kyp-know-your-product-ni-31-103/r1, paragraph (o) of the definition carries signal ACM-200 and is determinable. Paragraph (q) of the definition carries signal ACM-200 and is determinable. The chapter is as of 2026-11-04.\n\n## Coverage\n\nThe issuer's investor-relations page names six research houses: Research Capital Corporation, Leede Jones Gable, H.C. Wainwright Research, Raymond James, Ventum Capital Markets, and Rodman & Renshaw.\n\n## Open research\n\nNo openly published research notes were found on the record.\n\n## Licensed\n\nLicensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.\n\n## As-of depth\n\nThe market's vintage is not sealed, and no issuer years are sealed. The live record began on 2026-09-10. Years 2021 through 2026 are sealed in the store but are not served as of a date, and the as-of door answers not_sealed.\n\n## Sources\n\n9 source pages are named on this page; every value above carries its own source page and read date in the numbers.\n\n- https://www.tsx.com/json/company-directory/search/tsx/^* (identity.exchange)\n- https://www.marketscreener.com/quote/stock/SERNOVA-BIOTHERAPEUTICS-I-1411821/news/Sernova-Corp-has-Changed-its-Name-to-Sernova-Biotherapeutics-Inc-48916016 (identity.isin)\n- https://www.tsx.com/en/resource/571 (identity.sector)\n- https://mcp.ca-cm-kg.ai/events/TSX/SVA (the disclosure lines)\n- https://iiroc.mediaroom.com/index.php?s=2429&l=100 (the halt flag)\n- https://www.newsfilecorp.com/release/291710/Sernova-Biotherapeutics-Announces-Affirmative-Voting-Results-from-2026-Annual-General-Meeting-of-Shareholders (the auditor)\n- https://mcp.ca-cm-kg.ai/book/aio.json (the orderability chapter)\n- https://sernova.com/investors/stock-information/ (coverage)\n- https://mcp.ca-cm-kg.ai/record/TSX/SVA (the record)\n",
 "market": "CA",
 "node": "ca-cm-kg",
 "numbers": {
  "as_of_depth": {
   "issuer_years_sealed": [],
   "live_record_began": "2026-09-10",
   "node_history_from": null,
   "node_years_sealed": [],
   "note": "6 years are sealed in the CA store; their Replay split is not built, so the as-of door answers not_sealed and the record is the live record as of 2026-11-06",
   "record_version": 1,
   "sealed": false,
   "store_years_sealed_not_served": [
    "2021",
    "2022",
    "2023",
    "2024",
    "2025",
    "2026"
   ]
  },
  "auditor": {
   "auditor": {
    "read_by": "Tavily regex",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.newsfilecorp.com/release/291710/Sernova-Biotherapeutics-Announces-Affirmative-Voting-Results-from-2026-Annual-General-Meeting-of-Shareholders",
    "state": "sourced",
    "value": "Ernst & Young LLP"
   },
   "auditor_firm_id": {
    "market": "CA",
    "state": "not_on_record"
   },
   "auditor_location": {
    "market": "CA",
    "state": "not_on_record"
   },
   "changes": []
  },
  "cmr": "ca-cm-kg/TSX/SVA",
  "coverage": {
   "count": 6,
   "houses": [
    {
     "analyst": "Andre Uddin, Ph.D",
     "house": "Research Capital Corporation",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://sernova.com/investors/stock-information/",
     "state": "sourced"
    },
    {
     "analyst": "Doug Loe",
     "house": "Leede Jones Gable",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://sernova.com/investors/stock-information/",
     "state": "sourced"
    },
    {
     "analyst": "Joseph Pantginis, Ph.D",
     "house": "H.C. Wainwright Research",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://sernova.com/investors/stock-information/",
     "state": "sourced"
    },
    {
     "analyst": "Rahul Sarugaser & Michael Freeman",
     "house": "Raymond James",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://sernova.com/investors/stock-information/",
     "state": "sourced"
    },
    {
     "analyst": "Stefan Quenneville",
     "house": "Ventum Capital Markets",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://sernova.com/investors/stock-information/",
     "state": "sourced"
    },
    {
     "analyst": "Tony Butler",
     "house": "Rodman & Renshaw",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://sernova.com/investors/stock-information/",
     "state": "sourced"
    }
   ],
   "pages_checked": [
    {
     "page": "https://sernova.com/investors/stock-information/",
     "result": "read: 6 of 12 named houses found on the page"
    }
   ],
   "read_by": "Perplexity sonar (search) · page read by this rail",
   "read_date": "2026-11-12",
   "since": "not stated on the page read",
   "state": "found"
  },
  "disclosure": {
   "against": {
    "exchange": {
     "issuers": 2270,
     "median_cadence_gap_days": 16,
     "median_filings": 0,
     "median_latency_days": 3,
     "name": "TSX"
    },
    "sector": {
     "issuers": 200,
     "median_cadence_gap_days": 17.5,
     "median_filings": 7,
     "median_latency_days": 14,
     "name": "Life Sciences"
    }
   },
   "by_type": {
    "agm_record_date": 1,
    "newswire_release": 12
   },
   "cadence_median_gap_days": 14,
   "filing_days": 11,
   "filings": 13,
   "latency_days": 18,
   "latest": [
    {
     "category": null,
     "date": "2026-10-19",
     "source": "https://www.globenewswire.com/news-release/2026/10/19/3383268/0/en/seraxis-and-sernova-announce-appointment-of-former-fda-medical-officer-dr-patricia-beaston-as-chief-medical-officer-of-seraxis-and-post-merger-betanova-biotherapeutics.html",
     "title": "Seraxis and Sernova Announce Appointment of Former FDA",
     "type": "newswire_release"
    },
    {
     "category": null,
     "date": "2026-10-05",
     "source": "https://www.globenewswire.com/news-release/2026/10/05/3374406/0/en/sernova-and-seraxis-close-us-11-2-million-financing-to-fund-merger-to-become-betanova-biotherapeutics-and-advance-type-1-diabetes-cell-therapy-into-near-term-phase-1-2-clinical-tri.html",
     "title": "Sernova and Seraxis Close US$11.2 Million Financing to Fund",
     "type": "newswire_release"
    },
    {
     "category": null,
     "date": "2026-09-25",
     "source": "https://www.globenewswire.com/news-release/2026/09/25/3369037/0/en/sernova-biotherapeutics-to-participate-in-noble-capital-markets-emerging-growth-virtual-equity-conference.html",
     "title": "Sernova Biotherapeutics to Participate in Noble Capital",
     "type": "newswire_release"
    },
    {
     "category": null,
     "date": "2026-09-11",
     "source": "https://www.newsfilecorp.com/release/314074/Steven-Sangha-Announces-Voting-and-Support-Agreement-for-Sernova-Biotherapeutics-Inc.s-Proposed-Business-Combination-with-Seraxis-Holdings-Inc.",
     "title": "Steven Sangha Announces Voting and Support Agreement for Sernova Biotherapeutics Inc.'s Proposed Business Combination with Seraxis Holdings, Inc.",
     "type": "newswire_release"
    },
    {
     "category": null,
     "date": "2026-09-10",
     "source": "https://www.globenewswire.com/news-release/2026/09/10/3359341/0/en/sernova-biotherapeutics-to-participate-in-the-h-c-wainwright-28th-annual-global-investor-conference.html",
     "title": "Sernova Biotherapeutics to Participate in the H.C.",
     "type": "newswire_release"
    }
   ],
   "latest_filing_date": "2026-10-19",
   "read": "the node's event lines (list_events_since), as get_filings serves them",
   "source": "https://mcp.ca-cm-kg.ai/events/TSX/SVA",
   "window": {
    "from": "2025-11-06",
    "to": "2026-11-06"
   }
  },
  "identity": {
   "exchange": {
    "read_by": "tsx.com company directory (exchange list)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.tsx.com/json/company-directory/search/tsx/^*",
    "state": "sourced",
    "value": "TSX"
   },
   "isin": {
    "read_by": "Tavily search + regex extraction from page text",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.marketscreener.com/quote/stock/SERNOVA-BIOTHERAPEUTICS-I-1411821/news/Sernova-Corp-has-Changed-its-Name-to-Sernova-Biotherapeutics-Inc-48916016",
    "state": "confirmed",
    "value": "CA81752F1062"
   },
   "jurisdiction": {
    "market": "CA",
    "reason": "none found",
    "state": "not_on_record"
   },
   "lei": {
    "market": "CA",
    "reason": "ISIN not in the GLEIF ISIN-to-LEI mapping file",
    "state": "not_on_record"
   },
   "name": {
    "read_by": "tsx.com company directory (exchange list)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.tsx.com/json/company-directory/search/tsx/^*",
    "state": "sourced",
    "value": "Sernova Biotherapeutics Inc."
   },
   "sector": {
    "read_by": "TMX listed-companies workbook (exchange list, monthly; data month named in the source column)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.tsx.com/en/resource/571 (tsx-and-amp-tsxv-listed-companies-2026-08-14-en.xlsx, data as of 31-Jul-2026)",
    "state": "sourced",
    "value": "Life Sciences"
   },
   "security_type": {
    "read_by": "TMX listed-companies workbook (exchange list, monthly; data month named in the source column)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.tsx.com/en/resource/571 (tsx-and-amp-tsxv-listed-companies-2026-08-14-en.xlsx, data as of 31-Jul-2026)",
    "state": "sourced",
    "value": "Corporate"
   },
   "segment": {
    "market": "CA",
    "state": "not_on_record"
   },
   "ticker": {
    "read_by": "tsx.com company directory (exchange list)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.tsx.com/json/company-directory/search/tsx/^*",
    "state": "sourced",
    "value": "SVA"
   },
   "website": {
    "market": "CA",
    "state": "not_on_record"
   }
  },
  "licensed": {
   "columns": [
    "licensor",
    "entitlement",
    "title",
    "date",
    "source"
   ],
   "rows": [],
   "rule": "A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded."
  },
  "lifecycle": {
   "delisting": [],
   "domicile_change": [],
   "listing": [],
   "name_change": [],
   "segment_move": []
  },
  "market": "CA",
  "node": "ca-cm-kg",
  "numbers_hash": "sha256:797ba8eda29ad0444b04c97af803b6281a638c1e50fddfe42eaa582fd967963e",
  "open_research": {
   "read_date": "2026-11-12",
   "rows": [],
   "state": "none_found"
  },
  "orderability": {
   "chapter_as_of": "2026-11-04",
   "client_categories": [
    "Paragraph (o) of the definition",
    "Paragraph (q) of the definition"
   ],
   "outcomes": {
    "Paragraph (o) of the definition": {
     "determinable": true,
     "signal": "ACM-200"
    },
    "Paragraph (q) of the definition": {
     "determinable": true,
     "signal": "ACM-200"
    }
   },
   "read": {
    "basis": "one live read per instrument class, halt state and client category on this market; this issuer's group",
    "chapter": "https://mcp.ca-cm-kg.ai/book/aio.json",
    "door": "https://mcp.ca-cm-kg.ai/mcp",
    "tool": "get_orderability"
   },
   "rule_version": "acm-68000/ca/kyp-know-your-product-ni-31-103/r1",
   "section": "ca.aio.v11"
  },
  "record": {
   "as_of": "2026-11-06",
   "url": "https://mcp.ca-cm-kg.ai/record/TSX/SVA",
   "version": 1
  },
  "schema": "research-numbers v0.1 (USR-01, 2026-11-11)",
  "status": {
   "read_date": "2026-11-08",
   "source": "https://iiroc.mediaroom.com/index.php?s=2429&l=100",
   "value": "listed, not halted"
  }
 },
 "numbers_hash": "sha256:797ba8eda29ad0444b04c97af803b6281a638c1e50fddfe42eaa582fd967963e",
 "path": "/ca/TSX/SVA",
 "schema": "research-page v0.1 (USR-02, 2026-11-11)",
 "sections": [
  {
   "id": "identity",
   "text": "The issuer is Sernova Biotherapeutics Inc., listed on the TSX under ticker SVA. The ISIN is CA81752F1062 and the LEI is not on the record (ISIN not in the GLEIF ISIN-to-LEI mapping file). The security type is Corporate, the segment is not on the record, the sector is Life Sciences, and the jurisdiction is not on the record (none found). The listing status is listed, not halted.",
   "title": "Identity and listing"
  },
  {
   "id": "disclosure",
   "text": "The record holds 13 filings in the twelve months to 2026-11-06, across 11 filing days. The median gap between filing days is 14.0 days. The latest filing is dated 2026-10-19, is a newswire release, and is 18 days before the record date. On the TSX the median cadence gap is 16 days, the median filings count is 0.0, and the median latency is 3.0 days across 2,270 issuers. In the Life Sciences sector the median cadence gap is 17.5 days, the median filings count is 7.0, and the median latency is 14 days across 200 issuers.",
   "title": "The disclosure read"
  },
  {
   "id": "auditor",
   "text": "The auditor of record is Ernst & Young LLP, and its location is not on the record. The record holds no auditor changes.",
   "title": "Auditor"
  },
  {
   "id": "events",
   "text": "The record holds no listing, delisting, name change, domicile change or segment move events. The halt flag reads listed, not halted.",
   "title": "Events and halts"
  },
  {
   "id": "orderability",
   "text": "Under the rule version acm-68000/ca/kyp-know-your-product-ni-31-103/r1, paragraph (o) of the definition carries signal ACM-200 and is determinable. Paragraph (q) of the definition carries signal ACM-200 and is determinable. The chapter is as of 2026-11-04.",
   "title": "Orderability"
  },
  {
   "id": "coverage",
   "text": "The issuer's investor-relations page names six research houses: Research Capital Corporation, Leede Jones Gable, H.C. Wainwright Research, Raymond James, Ventum Capital Markets, and Rodman & Renshaw.",
   "title": "Coverage"
  },
  {
   "id": "open_research",
   "text": "No openly published research notes were found on the record.",
   "title": "Open research"
  },
  {
   "id": "licensed",
   "text": "Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.",
   "title": "Licensed"
  },
  {
   "id": "depth",
   "text": "The market's vintage is not sealed, and no issuer years are sealed. The live record began on 2026-09-10. Years 2021 through 2026 are sealed in the store but are not served as of a date, and the as-of door answers not_sealed.",
   "title": "As-of depth"
  },
  {
   "id": "sources",
   "text": "9 source pages are named on this page; every value above carries its own source page and read date in the numbers.",
   "title": "Sources"
  }
 ],
 "sources": [
  {
   "for": "identity.exchange",
   "source": "https://www.tsx.com/json/company-directory/search/tsx/^*"
  },
  {
   "for": "identity.isin",
   "source": "https://www.marketscreener.com/quote/stock/SERNOVA-BIOTHERAPEUTICS-I-1411821/news/Sernova-Corp-has-Changed-its-Name-to-Sernova-Biotherapeutics-Inc-48916016"
  },
  {
   "for": "identity.sector",
   "source": "https://www.tsx.com/en/resource/571"
  },
  {
   "for": "the disclosure lines",
   "source": "https://mcp.ca-cm-kg.ai/events/TSX/SVA"
  },
  {
   "for": "the halt flag",
   "source": "https://iiroc.mediaroom.com/index.php?s=2429&l=100"
  },
  {
   "for": "the auditor",
   "source": "https://www.newsfilecorp.com/release/291710/Sernova-Biotherapeutics-Announces-Affirmative-Voting-Results-from-2026-Annual-General-Meeting-of-Shareholders"
  },
  {
   "for": "the orderability chapter",
   "source": "https://mcp.ca-cm-kg.ai/book/aio.json"
  },
  {
   "for": "coverage",
   "source": "https://sernova.com/investors/stock-information/"
  },
  {
   "for": "the record",
   "source": "https://mcp.ca-cm-kg.ai/record/TSX/SVA"
  }
 ],
 "title": "Sernova Biotherapeutics Inc. (SVA) — research page",
 "writer": {
  "by": "Claude through the platform account, Haiku class; one pass; checked against the numbers",
  "engine": "claude-haiku-5-5"
 }
}